| PTCT:PTC Therapeutics, Inc. | | Charting | News | Options | |||||||||||||
| ||||||||||||||
| ||||||||||||||
| ||||||||||||||
0.00% $0.00
 Markets |
 Portfolio |
| |
| |
|
| |
|
|
|
|||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||
|
| Latest Story |
|
| PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program |
|
| PR Newswire |
|
PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that its Board of Directors has authorized a share repurchase program under which PTC may repurchase up to $500 million of the Company's outstanding shares of common stock, subject to market conditions. |
| Full Story → |
|
| Headline News |
|
| PTC Therapeutics to Participate in Upcoming Investor Conferences |
| 8:00a ET November 2 '26 PR Newswire |
|
|
| PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 4:30p ET October 30 '26 PR Newswire |
|
|
| PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results |
| 4:01p ET October 29 '26 PR Newswire |
|
| More News → |
| ||
|
|
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| November 9 '26. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Previous data from yesterday, November 9 '26. | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| Historical Price Performance | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Market data provided by 
News provided by   |
4.54%
0.51%
